Results 71 to 80 of about 16,532 (225)

Self unbound: ego dissolution in psychedelic experience [PDF]

, 2017
Users of psychedelic drugs often report that their sense of being a self or ‘I’ distinct from the rest of the world has diminished or altogether dissolved.
Gerrans, Philip, Letheby, Chris
core   +2 more sources

Near‐Death Experience During Emergency Ketamine Use: A Case Report

Brain and Behavior, Volume 15, Issue 10, October 2025.
We report a near‐death experience in a 73‐year‐old woman with acute respiratory failure who received an accidental 500 mg ketamine dose during intubation. Semi‐structured interviews revealed a vivid and evolving NDE narrative, followed by lasting psychological transformation, underscoring the clinical and research significance of NDEs in critical care.
Pauline Fritz, Anaïs Pichelin, Aurore Ancion, Naji Alnagger, Nicolas Lejeune, Alexandre Ghuysen, Olivia Gosseries, Charlotte Martial   +7 more
wiley   +1 more source

Mirtazapine decreases stimulatory effects of reboxetine on cortisol, adrenocorticotropin and prolactin secretion in healthy male subjects [PDF]

, 2004
Reboxetine is a selective noradrenaline reuptake inhibitor, whereas mirtazapine acts as an antagonist at noradrenergic alpha(2), serotonin (5-HT2), 5-HT3 and histamine H-1 receptors.
Baghai, Thomas C., Laakmann, G., Schule, C.   +2 more
core   +1 more source

Warfarin: pharmacological profile and drug interactions with antidepressants

Einstein (São Paulo), 2012
Oral anticoagulants are among the drugs with the greatest number of drug interactions. The concomitant use of several medications is a common practice in patients with cardiovascular problems, who often also present with depression; therefore, the ...
Juliana Souto Teles, Ellen Yukie Fukuda, David Feder   +2 more
doaj  

Assessment of the 3-substituted thietane-1,1-dioxide derivative antidepressant effect using rat model of depression induced by reserpine

Research Results in Pharmacology
Introduction: 3-ethoxythietane-1,1-dioxide (3ETD) is a novel molecule that has demonstrated significant antidepressant properties when administered intraperitoneally (i.p.) to mice once or repeatedly.
Irina L. Nikitina, Gulnara G. Gaisina, Elena E. Klen, Lyubov A. Tkachenko   +3 more
doaj   +1 more source

Antidepressants in Spine Surgery: A Systematic Review to Determine Benefits and Risks [PDF]

Asian Spine Journal, 2019
Antidepressant drugs can be advantageous in treating psychiatric and non-psychiatric illnesses, including spinal disorders. However, spine surgeons remain unfamiliar with the advantages and disadvantages of the use of antidepressant drugs as a part of ...
Ahmed B. Bayoumi, Oyku Ikizgul, Ceren Nur Karaali, Selma Bozkurt, Deniz Konya, Zafer Orkun Toktas   +5 more
doaj   +1 more source

Sarcopenic Obesity Phenotype Index (SOPi): A Population‐Based Study

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 5, October 2025.
ABSTRACT Background Sarcopenic obesity (SO) is a clinical condition defined by the coexistence of high body fat mass and low muscle function and mass, which increases the risk of adverse health outcomes, including disability and mortality. Early detection and frequent monitoring of SO are essential for preventive interventions and management strategies.
Elizabeth Benz, Alexandre Pinel, Christelle Guillet, Frederic Capel, Bruno Pereira, Dimitris Rizopoulos, Alfonso J. Cruz‐Jentoft, Doris Eglseer, Eva Topinkova, Rocco Barazzoni, Lorenzo M. Donini, Fernando Rivadeneira, Marinka Steur, Trudy Voortman, Peter J. M. Weijs, Josje D. Schoufour, Yves Boirie   +16 more
wiley   +1 more source

Insuficiência Hepática Aguda Induzida pela Trazodona e Diazepam [PDF]

, 2016
Most antidepressant agents have the potential to cause liver injury, even at therapeutic doses. Nevertheless, drug-induced liver injury (DILI) from antidepressant agents is a rare event. There is no way to prevent idiopathic DILI, but the severity of the
Barroso, E, Carvalhana, S, Ferreira, P, Oliveira, A, Perdigoto, R, Resende, M   +5 more
core   +1 more source

High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis—Patient Reported Outcome in Sweden

eJHaem, Volume 6, Issue 5, October 2025.
ABSTRACT Introduction With the purpose of identifying unmet needs of patients with acute leukemia, survivors were identified from the Swedish National Acute Leukemia registries. Methods At six months and at two years from diagnosis, patients were requested by mail to report outcome with focus on depression, sick leave, and sexual dysfunction.
Emma Bergfelt Lennmyr, Anna Lübking, Marie Abrahamsson, Gunnar Juliusson, Martin Höglund, Heléne Hallböök   +5 more
wiley   +1 more source

Lithium Augmentation in Treatment‐Resistant Depression: A Qualitative Review of the Literature

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 688-701, October 2025.
ABSTRACT Depression is the leading cause of disability worldwide, affecting people of all ages. Both pharmacological and non‐pharmacological therapies are available for its treatment. However, some patients do not respond to first‐line pharmacological interventions, referred to as treatment‐resistant depression (TRD).
Angela Acero‐González, Yahira Guzman, Nadia Juliana Proaños, Rosa‐Helena Bustos, María Aconcha, Ivan Guerrero, Laura Alejandra Martinez, Michael Berk, Seetal Dodd   +8 more
wiley   +1 more source